Ledger.Open graph →
SEC Form D · filed December 21, 2021

Addex Therapeutics Ltd

Offering
$5.9M
Sold
$5.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GENEVA, V8
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Jean-Philippe Rocher · Geneva, V8ExecMikhail Kalinichev · Geneva, V8ExecTimothy Dyer · Geneva, V8Exec · DirectorRoger Mills · Geneva, V8Exec · DirectorRaymond Hill · Geneva, V8DirectorRobert Lutjens · Geneva, V8ExecVincent Lawton · Geneva, V8DirectorJake Nunn · Menlo Park, CADirectorIsaac Manke · New York, NYDirectorRyan Gibson · Golden, COExec · DirectorBen Lapidus · Golden, CODirectorWhitney Hamm · Golden, COExecJohn Garry · Brooklyn, NYExecAdam Mcgough · Sandy, UTDirectorAaron Saunders · Golden, CODirectorAlexander Browning · London, United KingdomExec · DirectorChad Schneider · Golden, CODirectorGreg Litvak · Denver, COExecMorgan Beschle · New York, NYExec · DirectorKim Patrick · Newton, MAExecAudent Gam Fund I GP, LLC · WEST HOLLYWOOD, CADirectorJohn M. Hughes · WEST HOLLYWOOD, CAExec · DirectorGregg M. Kaplan · WEST HOLLYWOOD, CAExecAudent Global Asset Management, LLC · WEST HOLLYWOOD, CADirectorPaul Feinstein · WEST HOLLYWOOD, CAExecAerste Howells · New York, NYDirectorRob Dilling · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗